How Korean Biotech Can Overcome Investment, Regulatory Hurdles

Synergistic Partnerships With Japan

 
• By Jung Won Shin
  
Bioplus Interphex Korea 2025
A panel session at Bioplus Interphex Korea 2025 (Jung Won Shin)

More from Conferences

More from Scrip